Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at ...

The out-of-pocket cost cap of $£35 at participating ... and less than $8 in the UK. Eli Lilly together with Sanofi and Novo Nordisk make up 90% of the US market for insulin.

Ben Hargreaves explains how Eli Lilly decided to cap its insulin price ... guarantee to Medicare beneficiaries that insulin costs would be capped at $35. In California, the state had used $ ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big Pharma is coughing up cash to work with them on radiopharmaceuticals ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned ...

1,2 The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the ...

Eli Lilly & Co. tapped the US investment-grade bond market on Monday to help finance its roughly $2.5 billion purchase of a cancer drug from Scorpion Therapeutics Inc. The pharmaceutical company ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...